| __timestamp | Cytokinetics, Incorporated | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 165772000 |
| Thursday, January 1, 2015 | 19667000 | 196614000 |
| Friday, January 1, 2016 | 27823000 | 303251000 |
| Sunday, January 1, 2017 | 36468000 | 366406000 |
| Monday, January 1, 2018 | 31282000 | 434407000 |
| Tuesday, January 1, 2019 | 39610000 | 468711000 |
| Wednesday, January 1, 2020 | 52820000 | 516922000 |
| Friday, January 1, 2021 | 96803000 | 739560000 |
| Saturday, January 1, 2022 | 177977000 | 1002140000 |
| Sunday, January 1, 2023 | 173612000 | 1161300000 |
| Monday, January 1, 2024 | 1242157000 |
Data in motion
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Incyte Corporation and Cytokinetics, Incorporated from 2014 to 2023. Over this period, Incyte's SG&A expenses have consistently outpaced those of Cytokinetics, reflecting its larger scale and broader market reach. In 2023, Incyte's expenses were approximately 570% higher than Cytokinetics, highlighting its significant investment in administrative and sales functions. Notably, both companies saw a marked increase in expenses in 2022, with Cytokinetics experiencing a 84% rise from the previous year, possibly indicating strategic expansions or increased operational activities. This trend underscores the dynamic nature of the biotech industry, where companies must balance growth with cost management to maintain competitive advantage.
Bristol-Myers Squibb Company and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Vertex Pharmaceuticals Incorporated and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Incyte Corporation vs Summit Therapeutics Inc.
Incyte Corporation or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Incyte Corporation vs PTC Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Incyte Corporation and Perrigo Company plc
Breaking Down SG&A Expenses: Incyte Corporation vs BioCryst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and CymaBay Therapeutics, Inc.
Breaking Down SG&A Expenses: Cytokinetics, Incorporated vs Ultragenyx Pharmaceutical Inc.
Cytokinetics, Incorporated and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Novavax, Inc.